Selenium intakes may be "suboptimal" for prostate cancer risk reduction -- Harvard study.
This article was originally published in The Tan Sheet
Executive Summary
SELENIUM RECOMMENDED INTAKE MAY BE "SUBOPTIMAL" FOR PROSTATE CANCER risk reduction, Kazuko Yoshizawa, Harvard School of Public Health, et al., state in a study in the Aug. 19 Journal of the National Cancer Institute. The researchers report a "strong inverse association between the prediagnostic selenium level assessed" in study participants and the risk of advanced prostate cancer. Higher selenium intake levels among participants, as measured in toenail clippings collected by the researchers, were found to be associated with a lower risk of advanced prostate cancer.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning